These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33178596)

  • 41. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
    Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
    Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
    Yang L; He Y; Zhang Z; Wang W
    PeerJ; 2019; 7():e8245. PubMed ID: 31844595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
    Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
    Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human protein-RNA interaction network is highly stable across mammals.
    Ramakrishnan A; Janga SC
    BMC Genomics; 2019 Dec; 20(Suppl 12):1004. PubMed ID: 31888461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas.
    Yu S; Zhang J; Ding Y; Kang X; Pu X
    Front Genet; 2022; 13():937623. PubMed ID: 36147491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RNA-Seq profiling reveals aberrant RNA splicing in patient with adult acute myeloid leukemia during treatment.
    Li XY; Yao X; Li SN; Suo AL; Ruan ZP; Liang X; Kong Y; Zhang WG; Yao Y
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1426-33. PubMed ID: 24867525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis.
    Wang X; Wang P; Ge L; Wang J; Naqvi SMAS; Hu S
    Oncol Lett; 2020 Oct; 20(4):12. PubMed ID: 32774485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives.
    Kang D; Lee Y; Lee JS
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32967226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events.
    Wu HY; Wei Y; Liu LM; Chen ZB; Hu QP; Pan SL
    Oncol Lett; 2019 Nov; 18(5):4677-4690. PubMed ID: 31611977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
    Xing L; Zhang X; Tong D
    DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
    Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.
    Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y
    Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A deep boosting based approach for capturing the sequence binding preferences of RNA-binding proteins from high-throughput CLIP-seq data.
    Li S; Dong F; Wu Y; Zhang S; Zhang C; Liu X; Jiang T; Zeng J
    Nucleic Acids Res; 2017 Aug; 45(14):e129. PubMed ID: 28575488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splicing in a single neuron is coordinately controlled by RNA binding proteins and transcription factors.
    Thompson M; Bixby R; Dalton R; Vandenburg A; Calarco JA; Norris AD
    Elife; 2019 Jul; 8():. PubMed ID: 31322498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart.
    Belanger K; Nutter CA; Li J; Tasnim S; Liu P; Yu P; Kuyumcu-Martinez MN
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3205-3211. PubMed ID: 30158053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
    Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
    Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Identification of RNA-Binding Proteins Functionally Associated with Tumor Progression in Gastrointestinal Cancer.
    Konishi H; Kashima S; Goto T; Ando K; Sakatani A; Tanaka H; Ueno N; Moriichi K; Okumura T; Fujiya M
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
    Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
    Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.